GlassScriptPhysician profile
Aaron M Petersen
NPI 1972575140
$2,468.81
in general payments reported to CMS, 2019-2025
17 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $17.73 · 2021: $165 · 2022: $158 · 2023: $58.62 · 2024: $1,398 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $1,052 · Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $1,052.46 |
| Food and Beverage | $545.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $1,052.46 | 2024 | |
| Coopervision INC. | $359.60 | 2019 | |
| Alcon Vision LLC | $216.98 | 2019-2024 | Clareon |
| Aerie Pharmaceuticals, INC. | $205.76 | 2019-2021 | |
| Rxsight INC | $132.83 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Ocular Therapeutix, INC. | $107.48 | 2022-2025 | Dextenza |
| Johnson & Johnson Surgical Vision, INC. | $101.05 | 2022-2024 | Tecnis Simplicity |
| Glaukos Corporation | $59.21 | 2024-2025 | Istent Infinite, Idosetr, Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.17 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $40.32 | 2025 | Omidria |
| Mallinckrodt Hospital Products INC. | $32.19 | 2022 | |
| Abbvie INC. | $28.90 | 2023 | |
| Bausch & Lomb Americas INC. | $23.12 | 2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $17.73 | 2020 | |
| Genentech USA, INC. | $16.83 | 2023 | Vabysmo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.29 | 2021 | |
| Horizon Therapeutics Plc | $12.89 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.